New panel discussion: New Developments in Treatment for Bleeding Disorders – Novel Therapies, is a cure for hemophilia around the corner?
While clotting factor concentrates remain, by far, the mainstay of the management of hemophilia, a number of novel therapies under development have the potential to dramatically change the treatment landscape. Leading hematologists and patient advocates from around the world debate the potential of factor mimetics, antithrombin therapies, and gene therapy to change the lives of all people living with bleeding disorders.
Panel: David Lillicrap, Edward Tuddenham, Glenn Pierce, Declan Noone, chaired by David Page.
